Life Science

A hydrophobic derivative of the class I and class II HDAC inhibitor SAHA that demonstrates &gt60% inhibition of HDAC1 and HDAC6 activity in a deacetylase activity assay inhibits proliferation of SK-BR-3 breast-derived, HT29 colon-derived, and U937

A hydrophobic derivative of the class I and class II HDAC inhibitor SAHA that demonstrates &gt60% inhibition of HDAC1 and HDAC6 activity in a deacetylase activity assay inhibits proliferation of SK-BR-3 breast-derived, HT29 colon-derived, and U937

A hydrophobic derivative of the class I and class II HDAC inhibitor SAHA that demonstrates &gt60% inhibition of HDAC1 and HDAC6 activity in a deacetylase activity assay inhibits proliferation of SK-BR-3 breast-derived, HT29 colon-derived, and U937

A synthetic intermediate useful for pharmaceutical synthesis.

A synthetic intermediate useful for pharmaceutical synthesis.

A synthetic intermediate useful for pharmaceutical synthesis.

An erlotinib analog characterized by the addition of a methyl group at the four position of the phenyl group.

An erlotinib analog characterized by the addition of a methyl group at the four position of the phenyl group.

An erlotinib analog characterized by the addition of a methyl group at the four position of the phenyl group.

A branched chain primary alcohol with antimicrobial effects.

A branched chain primary alcohol with antimicrobial effects.

A branched chain primary alcohol with antimicrobial effects.